Prenetics Global (PRE) Competitors $13.70 +1.31 (+10.57%) Closing price 04:00 PM EasternExtended Trading$13.65 -0.05 (-0.36%) As of 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRE vs. LAB, CTKB, SENS, QSI, FEIM, MASS, QTRX, OWLT, RPID, and KEQUShould you be buying Prenetics Global stock or one of its competitors? The main competitors of Prenetics Global include Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Frequency Electronics (FEIM), 908 Devices (MASS), Quanterix (QTRX), Owlet (OWLT), Rapid Micro Biosystems (RPID), and Kewaunee Scientific (KEQU). These companies are all part of the "measuring and control equipment" industry. Prenetics Global vs. Its Competitors Standard BioTools Cytek Biosciences Senseonics Quantum-Si Frequency Electronics 908 Devices Quanterix Owlet Rapid Micro Biosystems Kewaunee Scientific Prenetics Global (NASDAQ:PRE) and Standard BioTools (NASDAQ:LAB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation. Do institutionals and insiders believe in PRE or LAB? 25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 53.7% of Standard BioTools shares are owned by institutional investors. 23.2% of Standard BioTools shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to PRE or LAB? In the previous week, Prenetics Global had 1 more articles in the media than Standard BioTools. MarketBeat recorded 4 mentions for Prenetics Global and 3 mentions for Standard BioTools. Prenetics Global's average media sentiment score of 1.03 beat Standard BioTools' score of 0.77 indicating that Prenetics Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prenetics Global 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Standard BioTools 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend PRE or LAB? Prenetics Global presently has a consensus target price of $9.00, indicating a potential downside of 34.31%. Standard BioTools has a consensus target price of $1.55, indicating a potential upside of 18.32%. Given Standard BioTools' higher probable upside, analysts clearly believe Standard BioTools is more favorable than Prenetics Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prenetics Global 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Standard BioTools 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is PRE or LAB more profitable? Standard BioTools has a net margin of -69.08% compared to Prenetics Global's net margin of -87.92%. Standard BioTools' return on equity of -20.23% beat Prenetics Global's return on equity.Company Net Margins Return on Equity Return on Assets Prenetics Global-87.92% -31.05% -24.16% Standard BioTools -69.08%-20.23%-15.32% Which has more risk and volatility, PRE or LAB? Prenetics Global has a beta of 0.15, meaning that its stock price is 85% less volatile than the S&P 500. Comparatively, Standard BioTools has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Which has preferable earnings & valuation, PRE or LAB? Prenetics Global has higher earnings, but lower revenue than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrenetics Global$30.62M5.81-$46.30M-$3.99-3.43Standard BioTools$174.43M2.87-$138.88M-$0.32-4.09 SummaryStandard BioTools beats Prenetics Global on 9 of the 16 factors compared between the two stocks. Get Prenetics Global News Delivered to You Automatically Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRE vs. The Competition Export to ExcelMetricPrenetics GlobalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$177.83M$3.11B$5.74B$10.35BDividend YieldN/A2.36%5.53%4.58%P/E Ratio-3.4320.9076.3526.43Price / Sales5.81253.83466.9191.04Price / CashN/A46.3537.4661.85Price / Book1.049.8313.186.39Net Income-$46.30M-$52.73M$3.29B$271.22M7 Day Performance27.80%4.85%2.50%2.78%1 Month Performance88.97%6.37%4.60%7.35%1 Year Performance226.19%19.15%73.81%29.64% Prenetics Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PREPrenetics Global0.8079 of 5 stars$13.70+10.6%$9.00-34.3%+184.8%$177.83M$30.62M-3.431Positive NewsHigh Trading VolumeLABStandard BioTools2.703 of 5 stars$1.39-1.1%$1.55+11.9%-26.2%$529.06M$174.43M-4.33620CTKBCytek Biosciences1.928 of 5 stars$3.75-2.8%$5.60+49.2%-28.5%$475.17M$200.45M-74.70500Positive NewsSENSSenseonics2.2949 of 5 stars$0.46+0.7%$1.54+232.8%+32.6%$376.38M$25.47M-3.5590QSIQuantum-Si1.6211 of 5 stars$1.58-7.4%$3.48+120.6%+75.8%$318.93M$3.41M-2.32150News CoverageGap UpFEIMFrequency Electronics3.2963 of 5 stars$29.75-0.5%$43.00+44.6%+149.5%$290.21M$69.81M13.00200Analyst DowngradeMASS908 Devices2.2621 of 5 stars$7.57+0.2%$8.00+5.7%+115.7%$270.38M$59.63M-13.9660QTRXQuanterix1.3002 of 5 stars$5.46+0.1%$11.75+115.4%-60.8%$253.49M$137.42M-3.00460OWLTOwlet2.3741 of 5 stars$8.46-2.0%$10.25+21.2%+102.7%$144.41M$78.10M-2.42106News CoverageRPIDRapid Micro Biosystems2.9461 of 5 stars$3.25-2.6%$8.00+145.9%+276.9%$143.46M$28.05M-3.21200KEQUKewaunee Scientific0.8386 of 5 stars$44.54+1.2%N/A+31.2%$127.83M$240.47M10.781,239 Related Companies and Tools Related Companies LAB Alternatives CTKB Alternatives SENS Alternatives QSI Alternatives FEIM Alternatives MASS Alternatives QTRX Alternatives OWLT Alternatives RPID Alternatives KEQU Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRE) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prenetics Global Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Prenetics Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
